Literature DB >> 21830441

Decreased expression and aberrant hypermethylation of the SFRP genes in human gastric cancer.

Takashi Kinoshita1, Shuji Nomoto, Yasuhiro Kodera, Masahiko Koike, Michitaka Fujiwara, Akimasa Nakao.   

Abstract

BACKGROUND/AIMS: Expression of secreted frizzled-related protein (SFRP) genes is silenced by aberrant methylation of the promoter region in several cancers. SFRP genes have recently been mapped on chromosome 8p12-p12.1 (SFRP1), 4q31.3 (SFRP2) and 10q24.1 (SFRP5), respectively. Interestingly, the SFRP family genes are located where the frequent LOH have been shown in gastric cancer samples.
METHODOLOGY: Methylation status and expression of SFRP genes were investigated in gastric cancer cell lines and surgically resected specimens.
RESULTS: A significant decrease in the expression of SFRP1 and SFRP5 was observed in gastric cancer compared with corresponding normal gastric tissues. The SFRP1 gene was hypermethylated in all 35 cancer tissues and corresponding non-cancerous tissues, as well as all seven gastric cancer cell lines, whereas SFRP2 gene was methylated in 83% of cancer tissues and 69% of normal epithelium, and SFRP5 in 43% and 54% of the same groups, respectively. Although gender, age, tumor size, pathological type, depth of tumor and TNM stage were not significantly correlated with the expression of SFRP genes, a significant decrease in the SFRP1 expression score was observed among gastric cancer with lymph node metastasis.
CONCLUSION: These results indicate the possibility that SFRP1 and 5 genes function as tumor suppressors, the down-regulation of which not only contributes to carcinogenesis but is also associated to some extent with the metastatic potential of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21830441

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  15 in total

1.  Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition.

Authors:  Hiroyuki Mori; Tyler C Prestwich; Michael A Reid; Kenneth A Longo; Isabelle Gerin; William P Cawthorn; Vedrana S Susulic; Venkatesh Krishnan; Andy Greenfield; Ormond A Macdougald
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

2.  Low expression of RBMS3 and SFRP1 are associated with poor prognosis in patients with gastric cancer.

Authors:  Tao Zhang; Youliang Wu; Zheng Fang; Qiang Yan; Shangxin Zhang; Ruochuan Sun; Junaid Khaliq; Yongxiang Li
Journal:  Am J Cancer Res       Date:  2016-11-01       Impact factor: 6.166

Review 3.  Pathogenetic mechanisms in gastric cancer.

Authors:  Jing Shi; Yi-Ping Qu; Peng Hou
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

4.  Methylation of SFRP5 is related to multidrug resistance in leukemia cells.

Authors:  H Wang; X Wang; R Hu; W Yang; A Liao; C Zhao; J Zhang; Z Liu
Journal:  Cancer Gene Ther       Date:  2014-01-17       Impact factor: 5.987

5.  A novel monoclonal antibody to secreted frizzled-related protein 2 inhibits tumor growth.

Authors:  Emily Fontenot; Emma Rossi; Russell Mumper; Stephanie Snyder; Sharareh Siamakpour-Reihani; Ping Ma; Eleanor Hilliard; Bradley Bone; David Ketelsen; Charlene Santos; Cam Patterson; Nancy Klauber-DeMore
Journal:  Mol Cancer Ther       Date:  2013-04-19       Impact factor: 6.261

6.  Low expression of secreted frizzled-related protein 4 in aggressive pituitary adenoma.

Authors:  Youtu Wu; Jiwei Bai; Zhenye Li; Fei Wang; Lei Cao; Chunhui Liu; Shengyuan Yu; Guoqiang Yu; Yazhuo Zhang
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

7.  MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.

Authors:  Sabit Delic; Nadine Lottmann; Anja Stelzl; Franziska Liesenberg; Marietta Wolter; Silke Götze; Marc Zapatka; Yuzuru Shiio; Michael C Sabel; Jörg Felsberg; Guido Reifenberger; Markus J Riemenschneider
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

8.  Ultrasound molecular imaging of secreted frizzled related protein-2 expression in murine angiosarcoma.

Authors:  James K Tsuruta; Nancy Klauber-DeMore; Jason Streeter; Jennifer Samples; Cam Patterson; Russell J Mumper; David Ketelsen; Paul Dayton
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

9.  Genome-wide analysis of differentially expressed genes and splicing isoforms in clear cell renal cell carcinoma.

Authors:  Alessio Valletti; Margherita Gigante; Orazio Palumbo; Massimo Carella; Chiara Divella; Elisabetta Sbisà; Apollonia Tullo; Ernesto Picardi; Anna Maria D'Erchia; Michele Battaglia; Loreto Gesualdo; Graziano Pesole; Elena Ranieri
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

10.  Maintaining the unmethylated state.

Authors:  Steven S Smith
Journal:  Clin Epigenetics       Date:  2013-09-30       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.